Innovation methods of optimization of bone regeneration: platelet-rich plasma (literature review) (part 1)

Authors

DOI:

https://doi.org/10.15674/0030-598720173123-135

Keywords:

bone regeneration, platelet rich plasma, orthopedics, traumatology

Abstract

The issues of bone regeneration remain relevant even with the active development of biotechnology. The use of platelet-rich plasma to optimize osteoporosis is one of the promising directions in modern medicine.

Objective: to performa comparative analysis, to generalize and systematize the results of studies on the classification, methods of obtaining and the possibility of using plasma-enriched platelets in animal experiments, and also in clinical conditions.

Methods: publications over the past 20 years have been analyzed from the electronic databases of PubMed, Medline, abstracts, articles, abstracts, dissertations and other relational sources of scientific and medical information. Over 200 works have been found.

Results: based on the information collected, the following issues were highlighted: receiving and classifying platelet-rich plasma, studying the effect of platelet-rich plasma on cells in vitro, and the possibility of combining platelet-rich plasma with biomaterials in animal experiments. In addition, the possibility of using platelet-rich plasma to restore bone tissue in a clinic in vivo is considered. It has been established that the use of platelet-rich plasma is one of the most promising modern methods for optimizing bone regeneration. The safety, efficacy and cost-effectiveness of platelet-rich plasma use are well documented in scientific literature. However, the main disadvantage of platelet-rich plasma is insufficient strength characteristics, which is a very important parameter for using it to fill bone defects, especially of critical size, in the case of osteotomy and surgical treatment of cancer. In this regard, the combination of platelet-rich plasma with osteoplastic materials, mesenchymal cells and growth factors is of particular interest. However, there are many controversial issues that require additional studies to create a transplant with properties that are as close as possible to the biological characteristics of the bone. 

Author Biographies

Mykola Korzh

Sytenko Institute of Spine and Joint Pathology, Kharkiv. Ukraine

MD, Prof. in Orthopaedics and Traumatology

mykola.korzh47@gmail.com

Petro Vorontsov

Sytenko Institute of Spine and Joint Pathology, Kharkiv. Ukraine

PhD in Orthopaedics and Traumatology

vorontsov64@ukr.net

Iryna Vishnyakova

Sytenko Institute of Spine and Joint Pathology, Kharkiv. Ukraine

yellow_b@bk.ru

Kateryna Samoilova

Sytenko Institute of Spine and Joint Pathology, Kharkiv. Ukraine

samoylova_e@ukr.net

References

  1. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19:180–92. doi: 10.1634/stemcells.19-3-180.
  2. Goustin AS, Leof EB, Shipley GD, Moses HL. Growth factors and cancer. Cancer Research. 1986;46:1015–29.
  3. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987;327:239–42.
  4. Deuel TF. Polypeptide growth factors: roles in normal and abnormal cell growth. Ann Rev Cell Biol. 1987;3:443–92.
  5. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances. J Bone Joint Surg Br. 2007;89(3):417–20. doi: 10.1302/0301-620X.89B3.18491.
  6. Achkasov EE, Bezuglov EN, Ulyanov AA, et al. Application of autoplasma enriched with platelets in clinical practice. Biomedicine. 2013;4:46-59. (in Russian)
  7. Daikalo VP, Mastykov AN, Boloboshko KB. Plate-enriched platelets in the treatment of diseases and damage of the locomotor apparatus. Vestnik VGMU. 2011;10(4):6-12. (in Russian)
  8. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surgery. 2004;62(4):489-96.
  9. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-72. doi: 10.1177/0363546509349921.
  10. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638-46.
  11. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent. 2001;10(4):225-8.
  12. Ivanov PYu, Zhuravlev VP, Makeev OG. Application of plasma-rich platelets for prophylaxis of jaw atrophy before dental implantation. Vestnik Ural'skoyi Medicina Akademicheskoy Nauki. 2011;1:76-8. (in Russian)
  13. Nagata M, Messora M, Okamoto R, Campos N, Pola N, Esper L, Sbrana M, Fucini S, Garcia V, Bosco A. Influence of the proportion of particulate autogenous bone graft/platelet-rich plasma on bone healing in critical-size defects: an immunohistochemical analysis in rat calvaria. Bone. 2009;45(2):339-45. doi: 10.1016/j.bone.2009.04.246.
  14. Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T. Classification of platelet concentrates (Platelet-Rich Plasma- PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles, Ligaments and Tendons Journal. 2014;4(1):3–9.
  15. Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang. 2009;97(2):110-8. doi: 10.1111/j.1423-0410.2009.01188.x.
  16. Vogel JP, Szalay K, Geiger F, Kramer M, Richter W, Kasten P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate. Platelets. 2006;17(7):462-9. doi: 10.1080/09537100600758867.
  17. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials. 2003;24(18):3095-100.
  18. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res. 2002;13(3):529-55.
  19. Ogino Y, Ayukawa Y, Kukita T, Koyano K. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblastlike cells. Oral Surg Oral Med Oral Pathol Oral. Radiol Endod. 2006;101(6):724-9. doi: 10.1016/j.tripleo.2005.08.016.
  20. Gruber R, Karreth F, Kandler B, et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrowderived mesenchymal progenitor cells under in vitro conditions. Platelets. 2004;15(1):29–35. doi: 10.1080/09537100310001643999.
  21. Gruber R, Kandler B, Fischer MB, Watzek G. Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro. Clin Oral Implants Res. 2006;17(2):188-93. doi: 10.1111/j.1600-0501.2005.01216.x.
  22. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):707-13. doi: 10.1016/j.tripleo.2009.06.044.
  23. Kasten P, Vogel J, Geiger F, Niemeyer P, Luginbühl R, Szalay K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials. 2008;29(29):3983-92. doi: 10.1016/j.biomaterials.2008.06.014.
  24. Kasten P, Vogel J, Beyen I, Weiss S, Niemeyer P, Leo A, Lüginbuhl R. Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesenchymal stem cells on distinct calcium phosphate scaffolds: the specific surface area makes a difference. J Biomater. 2008;23(2):169-88. doi: 10.1177/0885328207088269.
  25. Cenni E, Perut F, Ciapetti G, Savarino L, Dallari D, Cenacchi A, Stagni C, Giunti A, Fornasari PM, Baldini N. In vitro evaluation of freeze-dried bone allografts combined with platelet rich plasma and human bone marrow stromal cells for tissue engineering. J Mater Sci Mater Med. 2009;20(1):45–50. doi: 10.1007/s10856-008-3544-9.
  26. Butcher A, Milner R, Ellis K, Watson JT, Horner A. Interaction of platelet-rich concentrate with bone graft materials: an in vitro study. J Orthop Trauma. 2009;2(3):195–200. doi: 10.1097/BOT.0b013e31819b35db.
  27. Zhang Z, Chen J, Jin D. Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: the role of receptor beta. Biochem Biophys Res Commun. 1998;251 (1):190-4. doi: 10.1006/bbrc.1998.9412.
  28. Weicht B, Maitz P, Kandler B, Fischer MB, Watzek G,Gruber R. Activated platelets positively regulate RANKL-mediated osteoclast differentiation. J Cell Biochem. 2007;102(5):1300-07. doi: 10.1002/jcb.21360.
  29. Gruber R, Karreth F, Fischer MB, Watzek G. Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. Bone. 2002;30(5):726-32. doi: 10.1016/ S8756-3282(02)00697-X.
  30. Ogino Y, Ayukawa Y, Kukita T, Atsuta I, Koyano K. Platelet-rich plasma suppresses osteoclastogenesis by promoting the secretion of osteoprotegerin. J Periodontal Res. 2009;44(2):217-24. doi: 10.1111/j.1600-0765.2008.01109.x.
  31. Gerard D, Carlson ER, Gotcher JE, Jacobs M. Effects of platelet-rich plasma at the cellular level on healing of autologous bonegrafted mandibular defects in dogs. J Oral Maxillofac Surg. 2007;65(4):721-7. doi: 10.1016/j.joms.2006.09.025.
  32. Towler DA. The osteogenic-angiogenic interface: novel insights into the biology of bone formation and fracture repair. Curr Osteoporos Rep. 2008;6(2):67–71.
  33. Brandi ML, Collin-Osdoby P. Vascular biology and the skeleton. J Bone Miner Res. 2006;21(2):183-92. doi: 10.1359/JBMR.050917.
  34. von Schroeder HP, Veillette CJ, Payandeh J, Qureshi A, Heersche JN. Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone. 2003;33(4):673-84. doi: 10.1016/S8756-3282(03)00215-1.
  35. Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg. 2002;109(7):2384-97.
  36. Kilian O, Flesch I, Wenisch S, Taborski B, Jork A, Schnettler R, Jonuleit T. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res. 2004;9:337-44.
  37. Bir SC, Esaki J, Marui A, Yamahara K, Tsubota H, Ikeda T, Sakata R. Angiogenic properties of sustained release platelet-rich plasma: characterization in vitro and in the ischemic hind limb of the mouse. J Vasc Surg. 2009;50(4):870-9. doi:
  38. Cenni E, Ciapetti G, Granchi D, Fotia C, Perut F, Giunti A, Baldini N. Endothelial cells incubated with platelet-rich plasma express PDGF-B and ICAM-1 and induce bone marrow stromal cell migration. J Orthop Res. 2009;27(11):1493-98. doi: 10.1002/jor.20896.
  39. Roukis TS, Zgonis T, Tiernan B. Autologous platelet-rich plasma for wound and osseous healing: a review of the literature and commercially available products. Adv Ther. 2006;23(2):218-37.
  40. Aghaloo TL, Moy PK, Freymiller EG. Evaluation of platelet-rich plasma in combination with anorganic bovine bone in the rabbit cranium: a pilot study. Int J Oral Maxillofac Implants. 2004;19(1):59–65.
  41. Jensen TB, Rahbek O, Overgaard S, Soballe K. Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs. J Orthop Res. 2004;22(3):653-8. doi: 10.1016/j.orthres.2003.10.006.
  42. Roldan JC, Jepsen S, Miller J, Freitag S, Rueger DC, Açil Y, Terheyden H.. Bone formation in the presence of plateletrich plasma versus bone morphogenetic protein-7. Bone. 2004;34(1):80–90. doi: http://dx.doi.org/10.1016/j.bone.2003.09.011.
  43. Yamada Y, Ueda M, Hibi H, Nagasaka T. Translational research for injectable tissueengineered bone regeneration using mesenchymal stem cells and platelet-richplasma: from basic research to clinical case study. Cell Transplant. 2004;13(4):343-55.
  44. Schneppendahl J, Jungbluth P, Lögters TT, Sager M, Wild M, Hakimi M, Windolf J, Grassmann JP. Treatment of a diaphyseal long-bone defect with autologous bone grafts and platelet-rich plasma in a rabbit model. Vet Comp Orthop Traumatol. 2015;28(3):171. doi: 10.3415/VCOT-14-05-0079.
  45. Batista MA. Comparison between the effects of platelet-rich plasma and bone marrow concentrate on defect consolidation in the rabbit tibia. Clinics (Sao Paulo). 2011;66(10):1787-92. doi: 10.1590/S1807-59322011001000018.
  46. Nagata MJ, Melo LG, Messora MR, Bomfim SR, Fucini SE, Garcia VG, Bosco AF, Okamoto T. Effect of platelet-rich plasma on bone healing of autogenous bone grafts in criticalsize defects. J Clin Periodontol. 2009;36(9):775-83. doi: 10.1111/j.1600-051X.2009.01450.x.
  47. Nagata MJ, Messora M, Pola N, Campos N, Vieira R, Esper LA, Sbrana M, Fucini S, Garcia V, Bosco A. Influence of the ratio of particulate autogenous bone graft/platelet-rich plasma on bone healing in critical-size defects: a histologic and histometric study in rat calvaria. J Orthop. Res 2010;28(4):468-73. doi: 10.1002/jor.21027.
  48. Hakimi M, Grassmann JP, Betsch M, Schneppendahl J, Gehrmann S, Hakimi AR, Kröpil P, Sager M, Herten M, Wild M, Windolf J, Jungbluth P. The composite of bone marrow concentrate and PRP as an alternative to autologous bone grafting. PLoS ONE. 2014;9(6):e100143. doi: 10.1371/journal.pone.0100143.
  49. Betsch M, Schneppendahl J, Thuns S, Herten M, Sager M, Jungbluth P, Hakimi M, Wild M. Bone marrow aspiration concentrate and platelet rich plasma for osteochondral repair in a porcine osteochondral defect model. PLOS ONE. 2013;8(8):e71602. doi: 10.1371/journal.pone.0071602.
  50. Sebben AD, Hoff G, Klein CP, Freitas TA, Assad C, Santos LA, Silva JB. Comparative study on use of platelet-rich plasma alone and in combination with alpha-tricalcium phosphate cement for bone repair in rats. Rev Bras Ortop. 2012;47(4):505-12. doi: 10.1016/S2255-4971(15)30137-3.
  51. Velich N, Kovács K, Huszár T, Semjén G, Reiczigel J, Szabó G, Suba Z. The effect of platelet-rich plasma on new bone formation by augmentation with osseoconductive bone substitute material in beagle dogs. Fogorv Sz. 2004;97(1):23-7.
  52. Intini G, Andreana S, Intini FE, Buhite RJ, Bobek LA. Calcium sulfate and platelet-rich plasma make a novel osteoinductive biomaterial for bone regeneration. J Transl Med. 2007;5:13. doi: 10.1186/1479-5876-5-13.
  53. Jungbluth P, Wild M, Grassmann JP, Ar E, Sager M, Herten M, Jäger M, Becker J, Windolf J, Hakimi M. Platelet-rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini-pigs. J Orthop Res. 2010;28(11):1448-55. doi: 10.1002/jor.21152.
  54. Peng W, Kim IK, Cho HY, Seo JH, Lee DH, Jang JM, Park SH. The healing effect of platelet-rich plasma on xenograft in peri-implant bone defects in rabbits. Maxillofac Plast Reconstr Surg. 2016;38(1):16. doi: 10.1186/s40902-016-0061-5.
  55. Cheng X, Lei D, Mao T, Yang S, Chen F, Wu W. Repair of critical bone defects with injectable platelet rich plasma/bone marrow-derived stromal cells composite: experimental study in rabbits. Ulus Travma Acil Cerrahi Derg. 2008;14(2):87–95.
  56. Atalay Y, Bozkurt MF, Gonul Y, Cakmak O, Agacayak KS, Köse I, Hazman O, Keles H, Turamanlar O, Eroglu M. The effects of amlodipine and platelet rich plasma on bone healing in rats. Drug Des Devel Ther. 2015;9:1973-81. doi: 10.2147/DDDT.S80778.
  57. Fuerst G, Gruber R, Tangl S, Sanroman F, Watzek G. Enhanced bone-to-implant contact by platelet-released growth factors in mandibular cortical bone: a histomorphometric study in minipigs. Int J Oral Maxillofac Implants. 2003;18(5):685-90.
  58. Choi BH, Im CJ, Huh JY, Suh JJ, Lee SH. Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. Int J Oral Maxillofac Surg. 2004;33(1):56-9. doi: 10.1054/ijom.2003.0466.
  59. Thor A, Franke-Stenport V, Johansson CB, Rasmusson L. Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results. Int J Oral Maxillofac Surg. 2007;36(12):1164-71. doi: 10.1016/j.ijom.2007.05.023.
  60. Wiltfang J, Kloss FR, Kessler P, Nkenke E, Schultze-Mosgau S, Zimmermann R, Schlegel KA. Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. Clin Oral Implants Res. 2004;15(2):187-93. doi: 10.1111/j.1600-0501.2004.00980.x.
  61. Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate cortico-cancellous bone grafts and platelet rich plasma in goats. Int J Oral Maxillofac Surg. 2004;33(1):48–55. doi: 10.1054/ijom.2003.0452.
  62. Dallari D, Fini M, Stagni C, Torricelli P, Nicoli Aldini N, Giavaresi G, Cenni E, Baldini N, Cenacchi A, Bassi A, Giardino R, Fornasari PM, Giunti A. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res. 2006;24(5):877-88. doi: 10.1002/jor.20112.
  63. Fontana S, Olmedo DG, Linares JA, Guglielmotti MB, Crosa ME. Effect of platelet-rich plasma on the periimplant bone response: an experimental study. Implant Dent. 2004;13(1):73-8.
  64. Por YC, Barceló CR, Salyer KE, Genecov DG, Troxel K, Gendler E, Elsalanty ME, Opperman LA. Bone generation in the reconstruction of a critical size calvarial defect in an experimental model. Ann Acad Med Singapore. 2007;36(11):911-9.
  65. Khusainova LR. Complex method of surgical treatment of periodontal tissue pathology with the use of Alloplant biomaterial and platelet-rich fibrin. Available from: http://reg-surgery.ru/1_2008/ articles_ru/husainova.pdf. (in Russian)
  66. Gawai KT, Sobhana CR. Clinical evaluation of use of platelet rich plasma in bone healing. J Maxillofac Oral Surg. 2015;14(1):67–80. doi: 10.1007/s12663-013-0605-5.
  67. Penteado LA, Colombo CE, Penteado RA, Assis AO, Gurgel BC. Evaluation of bioactive glass and platelet-rich plasma for bone healing in rabbit calvarial defects. J Oral Sci. 2013;55(3):225-32.
  68. 68. Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br. 2009;91(8):987-96. doi: 10.1302/0301-620X.91B8.22546.
  69. 69. Galasso O, Mariconda M, Romano G, Capuano N, Romano L, Iannò B, Milano C. Expandable intramedullary nailing and platelet rich plasma to treat long bone non-unions. J Orthop. Traumatol. 2008;9(3):129-34. doi: 10.1007/s10195-008-0021-7.
  70. Ghaffarpasand F, Dehghankhalili M, Shahrezaei M. Platelet-rich plasma for traumatic non-union fractures: a novel but controversial bone regeneration strategy. Bull Emerg Trauma. 2013;1(3):99–101.
  71. Kesyan GA, Berchenko GN, Urazgildeev RZ, et al. Combined use of plateau enriched autoplasma and complex biocomposite material in the complex treatment of patients with long non-transplanted fractures and false joints of long limb bones. The Journal of Traumatology and Orthopedics. N.N. Prioryov. 2011;2:26–32. (in Russian)
  72. Kitoh H, Kawasumi M, Kaneko H, Ishiguro N. Differential effects of culture-expanded bone marrow cells on the regeneration of bone between the femoral and the tibial lengthening. J Pediatr Orthop. 2009;29(6):643-9. doi: 10.1097/BPO.0b013e3181b2afb2.
  73. Litvishko V, Popsuishapka O, Yaresko O. Stress-strain state of fibrin-blood clot and periosteum in the area of diaphyseal fracture under different conditions of fracture fragments fixation and its impact on the structural organization of regenerate / Orthopaedics, Traumatology and Prosthetics. 2016;1:62–71. doi: 10.15674/0030-59872016162-71. (in Ukrainian)
  74. Lee DH, Ryu KJ, Kim JW, Kang KC, Choi YR. Bone marrow aspirate concentrate and platelet-rich plasma enhanced bone healing in distraction osteogenesis of the tibia. Clin Orthop Relat Res. 2014;472(12):3789-97. doi: 10.1007/s11999-014-3548-3.
  75. Vadalà G, Di Martino A, Russo F, Tirindelli MC, De Felice L, Agostini F, Papalia R, Denaro V. Autologuos bone morrow concentrate combined with platelet-rich plasma enhance bone allograft potential to induce spinal fusion. J Biol Regul Homeost Agents. 2016; 4(1):165-72.
  76. Dedukh NV, Khmizov SA, Tikhonenko AA, et al The use of plasma-enriched platelets in injuries of the musculoskeletal system and their consequences. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2011;14(4):51–53. (in Russian)
  77. Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A, Nagae M, Arai Y, Kawata M, Kubo T. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol. 2008;215(3):837-45. doi: 10.1002/jcp.21368.
  78. Taylor MA, Norman TL, Clovis NB, Blaha JD. The response of rabbit patellar tendons after autologous blood injection. Med Sci Sports Exerc. 2002;34(1):70-3.
  79. Brehov VL. Surgical treatment of patients with defects of bone and cartilage tissues using platelet-rich autoplasma: abstract. dis the candidate of medscal sciences. Kursk, 2007. 14 p. (in Russian)
  80. D'Elia CO, de Rezende MU, Bitar AC, Tatsui N, Pécora JR, Hernandez AJ, Camanho GL. Comparison between platelet-rich plasma and autologous iliac grafts for tibial osteotomy. Cartilage. 2010;1(4):320-7. doi: 10.1177/1947603510376820.
  81. Samoday VG, Brekhov VL, Gaidukov VE. The use of rich platelet autoplasma in the surgical treatment of bone defect defects with bone continuity violation. System analysis and management in biomedical systems. 2007;2:493-5. (in Russian)
  82. Peerbooms JC, Colaris JW, Hakkert AA, Van Appeldorn M, Bruijn DJ, Den Oudsten BL, Gosens T. No positive bone healing after using platelet rich plasma in a skeletal defect. An observational prospective cohort study. Int Orthop. 2012;36(10):2113-9. doi: 10.1007/s00264-012-1603-9.
  83. Li S, Zhang C, Yuan T. Osteogenic potential of platelet-rich plasma combined with cells and artificial bone. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007;21(1):58–64.
  84. Rampichova M, Buzgo M, Mickova A, Vocetková K, Sovková V, Lukášová V, Filová E, Rustichelli F, Amler E. Platelet-functionalized three-dimensional poly-ε-caprolactone fibrous scaffold prepared using centrifugal spinning for delivery of growth factors. Int J Nanomedicine. 2017;12:347-61. doi: 10.2147/IJN.S120206.
  85. Rapp M, Svoboda D, Kaiser LM, Wessel M. M.Elastic stable intramedullary nailing (ESIN), Оrthoss® and gravitational platelet separation — system (GPS®): an effective method of treatment for pathologic fractures of bone cysts in children. BMC Musculoskelet Disord. 2011;12:45–50. doi: 10.1186/1471-2474-12-45.
  86. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67(4):525-44. doi: 10.1007/s00018-009-0210-4.
  87. Samoday VG. The use of platelet-rich autoplasma in the treatment of pseudoarthrosis and infected defects in bone tissue: Materials of the Third All-Russian Symposium with International Participation "Actual Problems of Clinical and Cellular Transplantology" (Moscow, April 25-26, 2007), рр. 148-50. (in Russian)

Downloads

How to Cite

Korzh, M., Vorontsov, P., Vishnyakova, I., & Samoilova, K. (2017). Innovation methods of optimization of bone regeneration: platelet-rich plasma (literature review) (part 1). ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (3), 123–135. https://doi.org/10.15674/0030-598720173123-135

Issue

No. 3 (2017)

Section

DIGESTS AND REVIEWS

License

Copyright (c) 2017 Mykola Korzh, Petro Vorontsov, Iryna Vishnyakova, Kateryna Samoilova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).